The number of people with susceptibility test result for rifampicin in Switzerland
Switzerland: The number of people with susceptibility test result for rifampicin was 220 in 2021. ▼ Falling
Latest (2021)
220
Change on year
up 28.7%
World rank
92nd
of 155 countries
All-time high
267
in 2017
All-time low
171
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Switzerland, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Switzerland recorded 220 for the number of people with susceptibility test result for rifampicin in 2021.
The figure is up 28.7% on the previous year and down 17.6% over five years.
Switzerland ranks 92nd of 155 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Switzerland, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 267 | — |
| 2018 | 261 | -2.2% |
| 2019 | 193 | -26.1% |
| 2020 | 171 | -11.4% |
| 2021 | 220 | +28.7% |
Switzerland compared with similar countries
- Switzerland's 220 is above the median for high income countries, which is 142, 1.5× the median. (61 countries reporting)
- Switzerland's 220 is below the median for Europe & Central Asia, which is 229.5, 96% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 240.33 | 193 | 267 | 3 |
| 2020s | 195.5 | 171 | 220 | 2 |
Countries ranked near Switzerland
- 89 Bosnia and Herzegovina 255 compare
- 90 Czechia 239 compare
- 91 Lebanon 228 compare
- 93 Armenia 209 compare
- 94 Venezuela, Bolivarian Republic of 198 compare
- 95 Macau, China 193 compare
More health data for Switzerland
- Un projection of annual infant deaths, annual growth rate -2.13 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.27 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,104 deaths per 1,000 people (2090)
- Number of infants who die before age 1 46 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2023)
- Population ages 00-04, female, annual growth rate 0.0481 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0233 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.0927 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Switzerland?
- The number of people with susceptibility test result for rifampicin in Switzerland was 220 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Switzerland?
- The highest recorded value was 267 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Switzerland?
- The lowest recorded value was 171 in 2020.
- How does Switzerland rank for the number of people with susceptibility test result for rifampicin?
- Switzerland ranks 92nd out of 155 countries with data for 2021.
- Where does this Switzerland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).